Early Phase 1 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old
- You have been newly diagnosed with liver cancer (hepatocellular carcinoma) for the first time — not a recurrence
- Your tumor is a single tumor measuring 5 cm or less in size
- At least two experienced senior liver surgeons have agreed that your tumor can be surgically removed
- Scans of your chest and abdomen show that the cancer has not spread to other parts of your body
- Your liver is functioning well, rated as "Child-Pugh Class A" (a measure of liver health — confirm with trial site)
- You, or your legal guardian, are able to understand the study details and sign a consent form
Who may not be able to join:
- After surgery, if the removed tissue turns out to be a different type of cancer than expected (such as certain rare liver or bile duct cancers — confirm with trial site)
- There is cancer found in the blood vessels or bile ducts of your liver
- You have had another type of cancer in the past, unless it was a fully cured early-stage skin cancer or a specific type of cervical cancer (confirm with trial site)
- Scans or surgery results show any remaining cancer, spread to lymph nodes, or incomplete removal of the tumor
- You have a moderate to severe buildup of fluid in your abdomen, or your liver function score is above a certain level
- You have an uncontrolled or significant buildup of fluid around your lungs or heart
- You have serious heart, lung, or kidney problems
- Your liver cancer has burst and you need emergency surgery
- You or your family are not able to understand the goals and conditions of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18980606725
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-Year Recurrence-Free Survival (RFS); Rate of Successful Fluorescence Staining
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.